2019 list of global top 10 biotech and pharmaceutical companies based on net income

This statistic shows the 2019 ranking of the top 10 biotech and pharmaceutical companies worldwide, based on net income. The values were taken from the Financial Times 2019 equity screener database. U.S. company Johnson & Johnson was ranked first with a net income of 16.3 billion U.S. dollars.

Biotech and pharmaceutical companies

Pfizer and Johnson & Johnson, both based in the United States, are among the world’s largest biotechnology and pharmaceutical companies based on their net incomes of approximately 15 billion U.S. dollars and 12 billion U.S. dollars, respectively, as of 2018. Pfizer generated 53 billion U.S. dollars of revenue in this year. Johnson & Johnson accumulated a market capitalization of 354 billion U.S. dollars as of 2018. Roche, a Switzerland-based company, is considered one of the leaders in biotech drugs, generating over 34 billion U.S. dollars in 2017 and is expected to reach some 42 billion U.S. dollars in biotech prescription drug revenue in 2024.
Lyrica is one of Pfizer’s most successful products. It is an anticonvulsant for neuropathic pain and is also used as therapy for partial seizures. In the EU and in Russia, Lyrica has also been approved to treat general anxiety disorder. In 2017, this prescription medication generated some five billion U.S. dollars in revenue. The United States and France boast the largest number of biotechnology companies in the world by a significant margin. As of 2014, there were 934 dedicated biotechnology companies in the United States and 1,284 companies in France.

2019 ranking of the global top 10 biotech and pharmaceutical companies based on net income

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

August 2019



Survey time period

as of August 2019

Supplementary notes

Release date represents date figures were accessed. The source gives no information if data is based on financial or calendar years nor about used exchange rates.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Monsanto-Bayer"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.